Влияние лефлуномида на показатели цитокинового статуса у больных псориатическим артритом

П. Д. Болотов, Мусина Флариса Сабирьяновна, Zarema Rimovna Khismatullina · Practical medicine · 2011

The article presents the results of the evaluation of cytokine status and effectiveness of leflunomide in patients with psoriatic arthritis (PsA). Revealed a significant increase in proinflammatory cytokines associated with the activity of systemic inflammation, and clinical and anatomical form of arthritis. It was established a clear symptom-modifying effect of leflunomide on joint syndrome in patients with PsA, the positive effects of the drug on cytokine status at 6 months of treatment.

Cited by 0 works.

Authors